Global Biosimilars Forum 2014

Key Topics

• Changeable regulatory environment
• The scientific authority behind the evolution of biosimilars
• Cost effective and flexible manufacture of high quality biosimilars
• The most excellence methods for grabbing a biosimilar from bench to market
• Biosimilar manufacture, process development
• What are themarket opportunities and commercial possibilities
• The latest best practices in clinical trial design and execution
• New techniques and tools for immunogenicity in development and the clinic
• Pricing of biosimilars
• Developing prosperous and competitive biosimilars

Who should Attend

Senior VPs, Directors, & Managers of:

• Biobetters
• Biosimilars
• Follow On Biologics
• Biological Safety
• Protein Characterisation
• Cell Line Development
• Clinical Trial Design
• Regulatory CMC
• Commercial Biologics